Retroelements versus APOBEC3 family members: No great escape from the magnificent seven

Frontiers in Microbiology

Volumn 3, Issue AUG, 2012, Pages

  Arias, Juan F ^a   Koyama, Takayoshi ^a   Kinomoto, Masanobu ^a   Tokunaga, Kenzo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Alu; APOBEC3; HIV 1; LINE 1; Restriction factors; Retroelements; Retrotransposition; Vif

Indexed keywords

EID: 84872649870     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00275     Document Type: Review

References (154)

1. Aguiar, R. S., Lovsin, N., Tanuri, A., and Peterlin, B. M. (2008). Vpr.A3A chimera inhibits HIV replication. J. Biol Chem. 283,2518-2525.
2. Athanikar, J. N., Badge, R. M., and Moran, J. V. (2004). A YY1-binding site is required for accurate human LINE-1 transcription initiation. Nucleic Acids Res. 32, 3846-3855.
3. Baillie, J. K., Barnett, M. W., Upton, K. R., Gerhardt, D. J., Richmond, T. A., De Sapio, F., Brennan, P. M., Rizzu, P., Smith, S., Fell, M., Talbot, R. T., Gustincich, S., Freeman, T. C., Mattick, J. S., Hume, D. A., Heutink, P., Carninci, P., Jeddeloh, J. A., and Faulkner, G. J. (2011). Somatic retrotransposition alters the genetic landscape of the human brain. Nature 479, 534-537.
4. Baumert, T. F., Rösler, C., Malim, M. H., and von Weizsäcker, F. (2007). Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology 46, 682-689.
5. Berger, A., Münk, C., Schweizer, M., Cichutek, K., Schüle, S., and Flory, E. (2010). Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member, A (APOBEC3A) correlates with efficient lentivirus infection of monocytes. J. Biol Chem. 285, 12248-12254.
6. Berger, G., Durand, S., Fargier, G., Nguyen, X.-N., Cordeil, S., Bouaziz, S., Muriaux, D., Darlix, J.L., and Cimarelli, A. (2011). APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog. 7:e1002221. doi: 10.1371/journal. ppat.1002221
7. Binka, M., Ooms, M., Steward, M., and Simon, V. (2012). The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.J. Virol. 86, 49-59.
8. Bishop, K. N., Holmes, R. K., and Malim, M. H. (2006). Antiviral potency of APOBEC proteins does not correlate with cyti-dine deamination. J. Virol. 80, 8450-8458.
9. Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S.-J., and Malim, M. H. (2004). Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14, 1392-1396.
10. Bogerd, H. P., Doehle, B. P., Wiegand, H. L., and Cullen, B. R. (2004). A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl Acad. Sci. U.S.A. 101, 3770-3774.
11. Bogerd, H. P., Tallmadge, R. L., Oaks, J. L., Carpenter, S., and Cullen, B. R. (2008). Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism. J. Virol. 82,11889-11901.
12. Bogerd, H. P., Wiegand, H. L., Doehle, B. P., Lueders, K. K., and Cullen, B. R. (2006a). APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells. Nucleic Acids Res. 34, 89-95.
13. Bogerd, H. P., Wiegand, H. L., Hulme, A. E., Garcia-Perez, J. L., OShea, K. S., Moran, J. V., and Cullen, B. R. (2006b). Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl. Acad. Sci. U.S.A. 103, 8780-8785.
14. Bourchis, D., and Bestor, T. H. (2004). Meiotic catastrophe and retrotrans-poson reactivation in male germ cells lacking Dnmt3L. Nature 431, 96-99.
15. Bulliard, Y., Turelli, P., Röhrig, U. F., Zoete, V., Mangeat, B., Michielin, O., and Trono, D. (2009). Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionar-ily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition. J. Virol. 83, 12611-12621.
16. Burden, A. F., Manley, N. C., Clark, A. D., Gartler, S. M., Laird, C. D., and Hansen, R. S. (2005). Hemimethylation and non-CpG methylation levels in a promoter region of human LINE-1 (L1) repeated elements. J. Biol. Chem. 280,14413-14419.
17. Chen, H., Lilley, C. E., Yu, Q., Lee, D. V., Chou, J., Narvaiza, I., Landau, N. R., and Weitzman, M. D. (2006). APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr. Biol. 16, 480-485.
18. Chiu, Y.L., Witkowska, H. E., Hall, S. C., Santiago, M., Soros, V. B., Esnault, C., Heidmann, T., and Greene, W. C. (2006). High-molecular-mass APOBEC3G complexes restrict Alu retrotrans position. Proc. Natl. Acad. Sci. U.S.A. 103, 15588-15593.
19. Claverie-Martin, F., Flores, C., Anton-Gamero, M., Gonzalez-Acosta, H., and Garcia-Nieto, V. (2005). The Alu insertion in the CLCN5 gene of a patient with Dents disease leads to exon 11 skipping.J. Hum. Genet. 50, 370-374.
20. Conticello, S. (2008). The AID/ APOBEC family of nucleic acid mutators. Genome Biol. 9, 229.
21. Cordaux, R., and Batzer, M. A. (2009). The impact of retrotransposons on human genome evolution. Nat. Rev. Genet. 10,691-703.
22. Cost, G. J., Feng, Q., Jacquier, A., and Boeke, J. D. (2002). Human L1 element target-primed reverse transcription in vitro. EMBO J. 21, 5899-5910.
23. Coufal, N. G., Garcia-Perez, J. L., Peng, G. E., Yeo, G. W., Mu, Y., Lovci, M. T., Morell, M., OShea, K. S., Moran, J. V., and Gage, E H. (2009). L1 retrotransposition in human neural progenitor cells. Nature 460, 1127-1131.
24. Crow, Y J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., Corry, P. C., Cowan, E M., Frints, S. G., Klepper, J., Livingston, J. H., Lynch, S. A., Massey, R. F., Meritet, J. F., Michaud, J. L., Ponsot, G., Voit, T., Lebon, P., Bonthron, D. T., Jackson, A. P., Barnes, D. E., and Lindahl, T. (2006). Mutations in the gene encoding the 3-5 DNA exonucle-ase TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat. Genet. 38,917-920.
25. Dörrschuck, E., Fischer, N., Bravo, I. G., Hanschmann, K.-M., Kuiper, H., Spötter, A., Möller, R., Cichutek, K., Münk, C., and Tönjes, R. R. (2011). Restriction of porcine endogenous retrovirus by porcine APOBEC3 cytidine deaminases. J. Virol. 85, 3842-3857.
26. Dang, Y., Abudu, A., Son, S., Harjes, E., Spearman, P., Matsuo, H., and Zheng, Y.-H. (2011). Identification of a single amino acid required for APOBEC3 antiretroviral cytidine deaminase activity. J. Virol. 85, 5691-5695.
27. Dang, Y., Wang, X., Esselman, W. J., and Zheng, Y.-H. (2006). Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family. J. Virol. 80, 10522-10533.
28. Deininger, P. L., and Batzer, M. A. (2002). Mammalian retroelements. Genome Res. 12, 1455-1465.
29. Delebecque, F., Suspene, R., Calattini, S., Casartelli, N., Saib, A., Froment, A., Wain-Hobson, S., Gessain, A., Vartanian, J. P., and Schwartz, O. (2006). Restriction of foamy viruses by APOBEC cytidine deaminases. J. Virol. 80, 605-614.
30. Dewannieux, M., Dupressoir, A., Harper, F., Pierron, G., and Heidmann, T. (2004). Identification of autonomous IAP LTR retrotransposons mobile in mammalian cells. Nat. Genet. 36, 534-539.
31. Dewannieux, M., Esnault, C., and Heidmann, T. (2003). LINE-mediated retrotransposition of marked Alu sequences. Nat. Genet. 35,41-48.
32. Doehle, B. P., Bogerd, H. P., Wiegand, H. L., Jouvenet, N., Bieniasz, P. D., Hunter, E., and Cullen, B. R. (2006). The betaretrovirus Mason-Pfizer monkey virus selectively excludes simian APOBEC3G from virion particles.J. Virol. 80, 12102-12108.
33. Doehle, B. P., Schäfer, A., and Cullen, B. R. (2005a). Human APOBEC3B is a potent inhibitor of HIV-1 infec-tivity and is resistant to HIV-1 Vif. Virology 339, 281-288.
34. Doehle, B. P., Schäfer, A., Wiegand, H. L., Bogerd, H. P., and Cullen, B. R. (2005b). Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J. Virol. 79, 8201-8207.
35. Duggal, N. K., Malik, H. S., and Emerman, M. (2011). The breadth of antiviral activity of Apobec3DE in chimpanzees has been driven by positive selection. J. Virol. 85, 11361-11371.
36. Dupressoir, A., and Heidmann, T. (1996). Germ line-specific expression of intracisternal A-particle retrotransposons in transgenic mice. Mol. Cell. Biol. 16, 4495-4503.
37. Dutko, J. A., Schafer, A., Kenny, A. E., Cullen, B. R., and Curcio, M. J. (2005). Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr. Biol. 15, 661-666.
38. Economou-Pachnis, A., and Tsichlis, P. N. (1985). Insertion of an Alu SINE in the human homologue of the Mlvi-2 locus. Nucleic Acids Res. 13, 8379-8387.
39. Esnault, C., Heidmann, O., Delebecque, F., Dewannieux, M., Ribet, D., Hance, A. J., Heidmann, T., and Schwartz, O. (2005). APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retro-viruses. Nature 433, 430-433.
40. Etard, C., Roostalu, U., and Strahle, U. (2010). Lack of Apobec2-related proteins causes a dystrophic muscle phenotype in zebrafish embryos. J. Cell Biol. 189,527-539.
41. Fan, J., Ma, G., Nosaka, K., Tanabe, J., Satou, Y., Koito, A., Wain-Hobson, S., Vartanian, J.P., and Matsuoka, M. (2010). APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 provi-ral genomes in vivo. J. Virol. 84, 7278-7287.
42. Goila-Gaur, R., Khan, M. A., Miyagi, E., Kao, S., and Strebel, K. (2007). Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity. Retrovirology 4, 61.
43. Groom, H. C. T., Yap, M. W., Galão, R. P., Neil, S. J. D., and Bishop, K. N. (2010). Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc. Natl. Acad. Sci. U.S.A. 107,5166-5171.
44. Hache, G., Liddament, M. T., and Harris, R. S. (2005). The retro-viral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cyto-sine deaminase domain. J. Biol. Chem. 280, 10920-10924.
45. Harari, A., Ooms, M., Mulder, L. C. F., and Simon, V (2009). Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H. J. Virol. 83, 295-303.
46. Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., and Malim, M. H. (2003). DNA deam-ination mediates innate immunity to retroviral infection. Cell 113, 803-809.
47. Harris, R. S., and Liddament, M. T. (2004). Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 4, 868-877.
48. Hohjoh, H., and Singer, M. E (1996). Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA. EMBO 15, 630-639.
49. Holmes, R. K., Koning, E A., Bishop, K. N., and Malim, M. H. (2007). APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. J. Biol. Chem. 282, 2587-2595.
50. Honjo, T., Nagaoka, H., Shinkura, R., and Muramatsu, M. (2005). AID to overcome the limitations of genomic information. Nat. Immunol. 6, 655-661.
51. Hulme, A. E., Bogerd, H. P., Cullen, B. R., and Moran, J. V (2007). Selective inhibition of Alu retrotransposition by APOBEC3G. Gene 390, 199-205.
52. Hultquist, J. F., Lengyel, J. A., Refsland, E. W., Larue, R. S., Lackey, L., Brown, W. L., and Harris, R. S. (2011). Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J. Virol. 85, 11220-11234.
53. Huthoff, H., and Towers, G. J. (2008). Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha. Trends Microbiol. 16, 612-619.
54. Ikeda, T., Abd El Galil, K. H., Tokunaga, K., Maeda, K., Sata, T., Sakaguchi, N., Heidmann, T., and Koito, A. (2011). Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 againstthe mobility of autonomous retro-transposons. Nucleic Acids Res. 39, 5538-5554.
55. Ikeda, T., Ohsugi, T., Kimura, T., Matsushita, S., Maeda, Y., Harada, S., and Koito, A. (2008). The antiretroviral potency of APOBEC1 deaminase from small animal species. Nucleic Acids Res. 36, 6859-6871.
56. Iwabu, Y., Kinomoto, M., Tatsumi, M., Fujita, H., Shimura, M., Tanaka, Y., Ishizaka, Y., Nolan, D., Mallal, S., Sata, T., and Tokunaga, K. (2010). Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes. J. Biol. Chem. 285, 35350-35358.
57. Iwatani, Y., Chan, D. S., Wang, F., Maynard, K. S., Sugiura, W., Gronenborn, A. M., Rouzina, I., Williams, M. C., Musier-Forsyth, K., and Levin, J. G. (2007). Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res. 35, 7096-7108.
58. Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., and Navaratnam, N. (2002). An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296.
59. Jeffs, A. R., Benjes, S. M., Smith, T. L., Sowerby, S. J., and Morris, C. M. (1998). The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia. Hum. Mol. Genet. 7, 767-776.
60. Jónsson, S. R., Larue, R. S., Stenglein, M. D., Fahrenkrug, S. C., Andrésdóttir, V., and Harris, R. S. (2007). The restriction of zoonotic PERV transmission by human APOBEC3G. PLoS ONE 2:e893. doi: 10.1371/journal.pone.0000893
61. Köck, J., and Blum, H. E. (2008). Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. J. Gen. Virol. 89, 1184-1191.
62. Kazazian, H. H., Wong, C., Youssoufian, H., Scott, A. F., Phillips, D. G., and Antonarakis, S. E. (1988). Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 332,164-166.
63. Khatua, A. K., Taylor, H. E., Hildreth, J. E. K., and Popik, W (2010). Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F. Virology 400, 68-75.
64. Kinomoto, M., Kanno, T., Shimura, M., Ishizaka, Y., Kojima, A., Kurata, T., Sata, T., and Tokunaga, K. (2007). All APOBEC3 family proteins differentially inhibit LINE-1 retro-transposition. Nucleic Acids Res. 35, 2955-2964.
65. Kobayashi, K., Nakahori, Y., Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M., Hamano, K., Sakakihara, Y., Nonaka, I., Nakagome, Y., Kanazawa, I., Nakamura, Y., Tokunaga, K., and Toda, T. (1998). An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394, 388-392.
66. Kobayashi, M., Takaori-Kondo, A., Shindo, K., Abudu, A., Fukunaga, K., and Uchiyama, T. (2004). APOBEC3G targets specific virus species. J. Virol. 78, 8238-8244.
67. Koning, F. A., Goujon, C., Bauby, H., and Malim, M. H. (2011). Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages. J. Virol. 85, 13448-13452.
68. Koning, F. A., Newman, E. N., Kim, E. Y., Kunstman, K. J., Wolinsky, S. M., and Malim, M. H. (2009). Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 83, 9474-9485.
69. Kriegs, J. O., Churakov, G., Jurka, J., Brosius, J., and Schmitz, J. (2007). Evolutionary history of 7SL RNA-derived SINEs in Supraprimates. Trends Genet. 23, 158-161.
70. Kubo, S., Seleme, M. D. C., Soifer, H. S., Perez, J. L. G., Moran, J. V., Kazazian, H. H., and Kasahara, N. (2006). L1 retrotransposition in nondividing and primary human somatic cells. Proc. Natl. Acad. Sci. U.S.A. 103, 8036-8041.
71. Lackey, L., Demorest, Z. L., Land, A. M., Hultquist, J. F., Brown, W. L., and Harris, R. S. (2012). APOBEC3B and AID have similar nuclear import mechanisms. J. Mol. Biol. 419, 301-314.
72. Langlois, M.A., Beale, R. C. L., Conticello, S. G., and Neuberger, M. S. (2005). Mutational com parison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities. Nucleic Acids Res. 33, 1913-1923.
73. Lee, Y N., and Bieniasz, P. D. (2007). Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog. 3:e10. doi: 10.1371/ journal.ppat.0030010
74. Lee, Y N., Malim, M. H., and Bieniasz, P. D. (2008). Hypermutation of an ancient human retrovirus by APOBEC3G. J. Virol. 82, 8762-8770.
75. Li, M. M. H., and Emerman, M. (2011). Polymorphism in human APOBEC3H affects a phenotype dominant for subcellular localization and antiviral activity. J. Virol. 85, 8197-8207.
76. Li, M. M., Wu, L. I., and Emerman, M. (2010). The range of human APOBEC3H sensitivity to lentiviral Vif proteins.J. Virol. 84, 88-95.
77. Li, X., Scaringe, W. A., Hill, K. A., Roberts, S., Mengos, A., Careri, D., Pinto, M. T., Kasper, C. K., and Sommer, S. S. (2001). Frequency of recent retrotransposition events in the human factor IX gene. Hum. Mutat. 17,511-519.
78. Malim, M. H. (2009). APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364, 675-687.
79. Mangeat, B., Turelli, P., Liao, S., and Trono, D. (2004). A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J. Biol. Chem. 279, 14481-14483.
80. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. (2003). Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103.
81. Marin, M., Rose, K. M., Kozak, S. L., and Kabat, D. (2003). HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9, 1398-1403.
82. Martin, S. L. (1991). Ribonucleoprotein particles with LINE-1 RNA in mouse embryonal carcinoma cells. Mol. Cell. Biol. 11, 4804-4807.
83. Meischl, C., Boer, M., Ahlin, A., and Roos, D. (2000). A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease. Eur. J. Hum. Genet. 8, 697-703.
84. Miki, Y., Nishisho, I., Horii, A., Miyoshi, Y., Utsunomiya, J., Kinzler, K. W., Vogelstein, B., and Nakamura, Y (1992). Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 52, 643-645.
85. Morse, B., Rotherg, P. G., South, V. J., Spandorfer, J. M., and Astrin, S. M. (1988). Insertional mutagen-esis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature 333, 87-90.
86. Muckenfuss, H., Hamdorf, M., Held, U., Perkovic, M., Löwer, J., Cichutek, K., Flory, E., Schumann, G. G., and Münk, C. (2006). APOBEC3 proteins inhibit human LINE-1 retrotransposition. J. Biol. Chem. 281,22161-22172.
87. Mukherjee, S., Mukhopadhyay, A., Banerjee, D., Chandak, G. R., and Ray, K. (2004). Molecular pathology of haemophilia B: identification of five novel mutations including a LINE 1 insertion in Indian patients. Haemophilia 10, 259-263.
88. Muotri, A. R., Chu, V. T., Marchetto, M. C. N., Deng, W., Moran, J. V., and Gage, F. H. (2005). Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 435, 903-910.
89. Muotri, A. R., Marchetto, M. C., Coufal, N. G., Oefner, R., Yeo, G., Nakashima, K., and Gage, F. H. (2010). L1 retrotransposition in neurons is modulated by MeCP2. Nature 468, 443-446.
90. Narita, N., Nishio, H., Kitoh, Y., Ishikawa, Y., Minami, R., Nakamura, H., and Matsuo, M. (1993). Insertion of a 5 truncated L1 element into the 3; end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy. J. Clin. Invest. 91, 1862-1867.
91. Narvaiza, I., Linfesty, D. C., Greener, B. N., Hakata, Y., Pintel, D. J., Logue, E., Landau, N. R., and Weitzman, M. D. (2009). Deaminase-independent inhi-bition of parvoviruses by the APOBEC3A cytidine deaminase. PLoS Pathog. 5:e1000439. doi: 10.1371/journal.ppat.1000439
92. Newman, E. N. C., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., and Sheehy, A. M. (2005). Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15, 166-170.
93. Niewiadomska, A. M., Tian, C., Tan, L., Wang, T., Sarkis, P. T. N., and Yu, X.F. (2007). Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association. J. Virol. 81,9577-9583.
94. OhAinle, M., Kerns, J. A., Li, M. M. H., Malik, H. S., and Emerman, M. (2008). Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 4, 249-259.
95. OhAinle, M., Kerns, J. A., Malik, H. S., and Emerman, M. (2006). Adaptive evolution and antiviral activity of the conserved mammalian cytidinedeaminase APOBEC3H. J. Virol. 80, 3853-3862.
96. Okeoma, C. M., Lovsin, N., Peterlin, B. M., and Ross, S. R. (2007). APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 445, 927-930.
97. Okeoma, C. M., Low, A., Bailis, W., Fan, H. Y., Peterlin, B. M., and Ross, S. R. (2009). Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. J. Virol. 83, 3486-3495.
98. Oldridge, M., Zackai, E. H., McDonald-McGinn, D. M., Iseki, S., Morriss-Kay, G. M., Twigg, S. R., Johnson, D., Wall, S. A., Jiang, W., Theda, C., Jabs, E. W., and Wilkie, A. O. (1999). De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am. J. Hum. Genet. 64, 446-461.
99. Ooms, M., Krikoni, A., Kress, A. K., Simon, V., and Münk, C. (2012). APOBEC3A, APOBEC3B and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type I (HTLV-1).J. Virol. 86, 6097-6108.
100. Ostertag, E. M., Goodier, J. L., Zhang, Y., and Kazazian, H. H. Jr. (2003). SVA elements are nonautonomous retrotransposons that cause disease in humans. Am. J. Hum. Genet. 73, 1444-1451.
101. Ostertag, E. M., and Kazazian, H. H. Jr. (2001). Biology of mammalian L1 retrotransposons. Annu. Rev. Genet. 35, 501-538.
102. Pak, V., Heidecker, G., Pathak, V. K., and Derse, D. (2011). The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B. J. Virol. 85, 8538-8547.
103. Paprotka, T., Venkatachari, N. J., Chaipan, C., Burdick, R., Delviks-Frankenberry, K. A., Hu, W.-S., and Pathak, V. K. (2010). Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J. Virol. 84, 5719-5729.
104. Peng, G., Greenwell-Wild, T., Nares, S., Jin, W., Lei, K. J., Rangel, Z. G., Munson, P. J., and Wahl, S. M. (2007). Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110, 393-400.
105. Perepelitsa-Belancio, V., and Deininger, P. (2003). RNA truncation by premature polyadenylation attenuates human mobile element activity. Nat. Genet. 35, 363-366.
106. Perkovic, M., Schmidt, S., Marino, D., Russell, R. A., Stauch, B., Hofmann, H., Kopietz, F., Kloke, B.-P., Zielonka, J., Ströver, H., Hermle, J., Lindemann, D., Pathak, V. K., Schneider, G., Löchelt, M., Cichutek, K., and Münk, C. (2009). Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J. Biol. Chem. 284, 5819-5826.
107. Rangwala, S., Zhang, L., and Kazazian, H. (2009). Many LINE1 elements contribute to the transcriptome of human somatic cells. Genome Biol. 10, R100.
108. Refsland, E. W., Stenglein, M. D., Shindo, K., Albin, J. S., Brown, W. L., and Harris, R. S. (2010). Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 38, 4274-4284.
109. Ribet, D., Dewannieux, M., and Heidmann, T. (2004). An active murine transposon family pair: retrotransposition of master MusD copies and ETn trans-mobilization. Genome Res. 14, 2261-2267.
110. Rohrer, J., Minegishi, Y., Richter, D., Eguiguren, J., and Conley, M. E. (1999). Unusual mutations in Btk: an insertion, a duplication, an inversion, and four large deletions. Clin. Immunol. 90, 28-37.
111. Russell, R. A., Wiegand, H. L., Moore, M. D., Schafer, A., McClure, M. O., and Cullen, B. R. (2005). Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretrovi-ral defense factors. J. Virol. 79, 8724-8731.
112. Sasada, A., Takaori-Kondo, A., Shirakawa, K., Kobayashi, M., Abudu, A., Hishizawa, M., Imada, K., Tanaka, Y., and Uchiyama, T. (2005). APOBEC3G targets human T-cell leukemia virus type 1. Retrovirology 2, 32.
113. Sato, Y., Probst, H. C., Tatsumi, R., Ikeuchi, Y., Neuberger, M. S., and Rada, C. (2010). Deficiency in APOBEC2 leads to a shift in muscle fiber type, diminished body mass, and myopathy. J. Biol. Chem. 285, 7111-7118.
114. Sawyer, S. L., Emerman, M., and Malik, H. S. (2004). Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoSBiol. 2:e275. doi: 10.1371/jour-nal.pbio.0020275
115. Schichman, S. A., Caligiuri, M. A., Strout, M. P., Carter, S. L., Gu, Y., Canaani, E., Bloomfield, C. D., and Croce, C. M. (1994). ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res. 54, 4277-4280.
116. Schmitt, K., Guo, K., Algaier, M., Ruiz, A., Cheng, F., Qiu, J., Wissing, S., Santiago, M. L., and Stephens, E. B. (2011). Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution. Virology 419,24-42.
117. Schröfelbauer, B., Chen, D., and Landau, N. R. (2004). A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc. Natl. Acad. Sci. U.S.A. 101, 3927-3932.
118. Schumacher, A. J., Haché, G., Macduff, D. A., Brown, W. L., and Harris, R. S. (2008). The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction. J. Virol. 82, 2652-2660.
119. Schumacher, A. J., Nissley, D. V., and Harris, R. S. (2005). APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc. Natl. Acad. Sci. U.S.A. 102,9854-9859.
120. Schumann, G. G. (2007). APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition. Biochem. Soc. Trans. 35, 637-642.
121. Sheehy, A. M., Gaddis, N. C., Choi, J. D., and Malim, M. H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
122. Sheehy, A. M., Gaddis, N. C., and Malim, M. H. (2003). The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9, 1404-1407.
123. Smith, H. C., Bennett, R. P., Kizilyer, A., McDougall, W. M., and Prohaska, K. M. (2012). Functions and regulation of the APOBEC family of proteins. Semin. Cell Dev. Biol. 23, 258-268.
124. Soifer, H. S., Zaragoza, A., Peyvan, M., Behlke, M. A., and Rossi, J. J. (2005). A potential role for RNA interference in controlling the activity of the human LINE-1 retro-transposon. Nucleic Acids Res. 33, 846-856.
125. Stenglein, M. D., and Harris, R. S. (2006). APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J. Biol. Chem. 281, 16837-16841.
126. Stetson, D. B., Ko, J. S., Heidmann, T., and Medzhitov, R. (2008). Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587-598.
127. Stopak, K., De Noronha, C., Yonemoto, W., and Greene, W. C. (2003). HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12, 591-601.
128. Suspène, R., Aynaud, M.M., Guétard, D., Henry, M., Eckhoff, G., Marchio, A., Pineau, P., Dejean, A., Vartanian, J.P., and Wain-Hobson, S. (2011a). Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc. Natl. Acad. Sci. U.S.A. 108, 4858-4863.
129. Suspène, R., Aynaud, M.M., Koch, S., Pasdeloup, D., Labetoulle, M., Gaertner, B., Vartanian, J.P., Meyerhans, A., and Wain-Hobson, S. (2011b). Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo. J. Virol. 85, 7594-7602.
130. Takeda, E., Tsuji-Kawahara, S., Sakamoto, M., Langlois, M. A., Neuberger, M. S., Rada, C., and Miyazawa, M. (2008). Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.J. Virol. 82, 10998-11008.
131. Tan, L., Sarkis, P. T., Wang, T., Tian, C., and Yu, X. F. (2009). Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1. FASEBJ. 23, 279-287.
132. Tchenio, T., Casella, J. F., and Heidmann, T. (2000). Members of the SRY family regulate the human LINE retrotransposons. Nucleic Acids Res. 28,411-415.
133. Teng, B., Burant, C. F., and Davidson, N. O. (1993). Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260, 1816-1819.
134. Turelli, P., Mangeat, B., Jost, S., Vianin, S., and Trono, D. (2004a). Inhibition of hepatitis B virus replication by APOBEC3G. Science 303, 1829.
135. Turelli, P., Vianin, S., and Trono, D. (2004b). The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay. J. Biol. Chem. 279,43371-43373.
136. van Den Hurk, J. a. J. M., van de Pol, D. J. R., Wissinger, B., van Driel, M. A., Hoefsloot, L. H., De Wijs, I. J., van den Born, L. I., Heckenlively, J. R., Brunner, H. G., Zrenner, E., Ropers, H.-H., and Cremers, F. P. M. (2003). Novel types of mutation in the choroideremia (CHM) gene: a full-length L1 insertion andan intronic mutation activating a cryptic exon. Hum. Genet. 113, 268-275.
137. Vartanian, J.P., Guétard, D., Henry, M., and Wain-Hobson, S. (2008). Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 320, 230-233.
138. Vonica, A., Rosa, A., Arduini, B. L., and Brivanlou, A. H. (2011). APOBEC2, a selective inhibitor of TGFbeta signaling, regulates left-right axis specification during early embryo-genesis. Dev. Biol. 350, 13-23.
139. Wallace, M. R., Andersen, L. B., Saulino, A. M., Gregory, P. E., Glover, T. W., and Collins, F. S. (1991). A de novo Alu insertion results in neurofibromatosis type 1. Nature 353, 864-866.
140. Walsh, C. P., Chaillet, J. R., and Bestor, T. H. (1998). Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat. Genet. 20, 116-117.
141. Wang, X., Abudu, A., Son, S., Dang, Y., Venta, P. J., and Zheng, Y.-H. (2011). Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity. J. Virol. 85, 3142-3152.
142. Wiegand, H. L., Doehle, B. P., Bogerd, H. P., and Cullen, B. R. (2004). A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBOJ. 23, 2451-2458.
143. Wiegand, H. L., and Cullen, B. R. (2007). Inhibition of alpharetro-virus replication by a range of human APOBEC3 proteins. J. Virol. 81,13694-13699.
144. Wilund, K. R., Yi, M., Campagna, F., Arca, M., Zuliani, G., Fellin, R., Ho, Y.-K., Garcia, J. V., Hobbs, H. H., and Cohen, J. C. (2002). Molecular mechanisms of autosomal recessive hypercholes-terolemia. Hum. Mol. Genet. 11, 3019-3030.
145. Wimmer, K., Callens, T., Wernstedt, A., and Messiaen, L. (2011). The NF1 gene contains hotspots for L1 endonuclease-dependent de novo insertion. PLoS Genet. 7:e1002371. doi: 10.1371/journal.pgen.1002371
146. Wissing, S., Montano, M., Garcia-Perez, J. L., Moran, J. V., and Greene, W C. (2011). Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells. J. Biol. Chem. 286, 36427-36437.
147. Yang, N., and Kazazian, H. H. Jr. (2006). L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat. Struct. Mol. Biol. 13, 763-771.
148. Yang, N., Zhang, L., Zhang, Y., and Kazazian, H. H. Jr. (2003). An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res. 31, 4929-4940.
149. Yang, Y., Guo, F., Cen, S., and Kleiman, L. (2007). Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F. Virology 365, 92-100.
150. Yoshida, K., Nakamura, A., Yazaki, M., Ikeda, S., and Takeda, S. (1998). Insertional mutation by transpos-able element, L1, in the DMD gene results in X-linked dilated car-diomyopathy. Hum. Mol. Genet. 7, 1129-1132.
151. Yu, Q., Chen, D., Konig, R., Mariani, R., Unutmaz, D., and Landau, N. R. (2004). APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem. 279, 53379-53386.
152. Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., and Gao, L. (2003). The cytidine deam-inase CEM15 induces hypermuta-tion in newly synthesized HIV-1 DNA. Nature 424, 94-98.
153. Zhen, A., Wang, T., Zhao, K., Xiong, Y., and Yu, X. F. (2010). A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity. J. Virol. 84, 1902-1911.
154. Zheng, Y H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., and Peterlin,B. M. (2004). Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78, 6073-6076.